An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination With Sargramostim in Adults With Metastatic Carcinoma
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Falimarev (Primary) ; Inalimarev (Primary) ; Sargramostim
- Indications Adenocarcinoma; Breast cancer; Cancer metastases; Colorectal cancer; Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2018 Status changed from active, no longer recruiting to completed.
- 01 Jun 2018 Status changed from active, no longer recruiting to completed.
- 15 May 2018 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.